|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 5.860 USD | -2.01% |
|
-2.33% | -4.87% |
| 10-05 | Lifevantage Corporation Approves A Change in Fiscal Year End from June 30 to December 31 | CI |
| 09-20 | LifeVantage Corporation(NasdaqCM:LFVN) dropped from S&P Global BMI Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 74.54M | |||||
| 1,165B | |||||
| 645B | |||||
| 504B | |||||
| 380B | |||||
| 363B |
Select your edition
All financial news and data tailored to specific country editions
